https://doi.org/10.1007/s12325-020-01466-z
X
Xiangbo Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
701
Citations
15
h-index
25
i10-index
Xiangbo Xu is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Liver Disease and Transplantation & Liver Disease Diagnosis and Treatment & Organ Transplantation Techniques and Outcomes. The author has an h-index of 15, co-authored 48 publications.
ORCID: 0000-0002-8561-6810Papers by this author
worksTerlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study
2020 · Advances in Therapy · 14 citations
Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures
2019 · Annals of Hepatology · 9 citations
https://doi.org/10.1016/j.aohep.2019.08.002
Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14790046
Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis
2024 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.25065885
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat